LANGER BIOMECHANICS GROUP INC
SC 13D/A, 1997-05-02
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Previous: CEL SCI CORP, DEF 14A, 1997-05-02
Next: UNITED OKLAHOMA BANKSHARES INC, SC 13D/A, 1997-05-02



United States
Securities and Exchange Commission
Washington, D.C.  20549


SCHEDULE 13D

Under the Securities Exchange Act of 1934
(Amendment No. 6)

Name of Issuer:   The Langer Biomechanics Group, Inc.
Title of Class of Securities:   Common Stock, $.02 Par Value
CUSIP Number:  515707107

Name, Address and Telephone Number of Person Authorized to Receive 
Notices and Communications:
Douglas T. Granat, 155 Pfingsten Road, Suite 360, Deerfield, 
Illinois  60015
847-405-9700

Date of Event which Requires Filing of this Statement:
April 18, 1997




CUSIP No. 515707107
Page 2 of 7 Pages	

1. Name of Reporting Person         Trigran Investments, L.P.		
                                    IRS No. 36-3778244

2. Check the appropriate box if a member of a group     (a) [ ]	
                                                        (b) [x]

3. SEC Use Only

4. Source of Funds     WC

5. Check Box if Disclosure of Legal Proceedings is Required Pursuant 
          to Items 2(d) or 2(e)  [ ]
          N/A

6. Citizenship or Place of Organization     Illinois

7. Sole Voting Power               See Item 5(b)

8. Shared Voting Power             See Item 5(b)

9. Sole Dispositive Power          See Item 5(b)

10. Shared Dispositive Power       See Item 5(b)     

11. Aggregate Amount Beneficially Owned by Each Reporting Person  530,753

12. Check Box if the Aggregate Amount in Row (11) 
       Excludes Certain Shares  [ ]

13. Percent of Class Represented by Amount in Row (11)     20.5%

14. Type of Reporting Person     PN



CUSIP No. 515707107
Page 3 of 7 Pages	

1. Name of Reporting Person         Kenneth Granat
                                    IRS No. ###-##-####

2. Check the appropriate box if a member of a group     (a) [ ]	
                                                        (b) [x]

3. SEC Use Only

4. Source of Funds     N/A

5. Check Box if Disclosure of Legal Proceedings is Required Pursuant 
          to Items 2(d) or 2(e)  [ ]
          N/A

6. Citizenship or Place of Organization     United States

7. Sole Voting Power               See Item 5(b)

8. Shared Voting Power             See Item 5(b)

9. Sole Dispositive Power          See Item 5(b)

10. Shared Dispositive Power       See Item 5(b)     

11. Aggregate Amount Beneficially Owned by Each Reporting Person  60,000

12. Check Box if the Aggregate Amount in Row (11) 
       Excludes Certain Shares  [ ]

13. Percent of Class Represented by Amount in Row (11)     2.3%

14. Type of Reporting Person     IN



CUSIP No. 515707107
Page 4 of 7 Pages	

1. Name of Reporting Person    The Granat Family Limited Partnership
                               IRS No. 36-3995726

2. Check the appropriate box if a member of a group     (a) [ ]	
                                                        (b) [x]

3. SEC Use Only

4. Source of Funds     PF

5. Check Box if Disclosure of Legal Proceedings is Required Pursuant 
          to Items 2(d) or 2(e)  [ ]
          N/A

6. Citizenship or Place of Organization     Illinois

7. Sole Voting Power               See Item 5(b)

8. Shared Voting Power             See Item 5(b)

9. Sole Dispositive Power          See Item 5(b)

10. Shared Dispositive Power       See Item 5(b)     

11. Aggregate Amount Beneficially Owned by Each Reporting Person  30,000

12. Check Box if the Aggregate Amount in Row (11) 
       Excludes Certain Shares  [ ]

13. Percent of Class Represented by Amount in Row (11)     1.2%

14. Type of Reporting Person     PN



CUSIP No. 515707107
Page 5 of 7 Pages	

AMENDMENT NO. 6
TO
SCHEDULE 13D

Item 1     Security and Issuer
               Common Stock, par value $.02 per share

               The Langer Biomechanics Group, Inc. (the "Issuer")
               450 Commack Road
               Deer Park, NY  11729

Except as expressly stated below, there have been no material changes 
in the facts and statements set forth in Schedule 13D, filed April 17, 
1993, as amended by Amendment No. 1, filed February 8, 1995, as 
amended by Amendment No. 2, filed June 7, 1995, as amended by 
Amendment No. 3, filed October 26, 1995, as amended by Amendment 
No. 4, filed April 9, 1996, and as amended by Amendment No. 5, filed 
January 15, 1997, with respect to the Common Stock, par value $.02 
per share, of  The Langer Biomechanics Group, Inc. (Where no material 
change has occurred with respect to items 2-8, inclusive, or a part 
thereof, of the Schedule 13D, as amended by Amendment No. 1, Amendment 
No. 2, Amendment No. 3, Amendment No. 4, and Amendment No. 5, such 
particular item or respective part thereof is omitted from this 
Amendment No. 6.)

Schedule 13D, as amended by Amendment No.1, Amendment No. 2, Amendment
No. 3, Amendment No. 4, Amendment No. 5, together with Amendment 
No. 6, is sometimes referred to herein as Schedule 13D, as amended.

Item 5           Interest in the Securities of the Issuer

     (a)  The aggregate number and percentage of the common stock
     (including options to purchase common stock) of the Issuer 
     beneficially owned by the Reporting Persons as of the date 
     of this filing is 620,753 shares or 24.0% as follows:

              % of Class of
            Shares Beneficially     Securities Identified
Person      Owned as of 5/2/97      in Item 1

1               530,753                  20.5%
2                60,000                   2.3%
3                30,000                   1.2%

     (b)  Person 1, through its general partner, Trigran Investments, 
     Inc., has sole power to vote and sole power to dispose of the 
     securities listed in (a) above for person 1.

     Each of Douglas Granat, Kenneth Granat and Lawrence Oberman, 
     as officers of the general partner of Person 1, have shared 
     power to vote and shared power to dispose of the securities 
     listed in (a) above for person 1.

     Person 2 has sole power to vote and sole power to dispose of 
     the securities listed in (a) above for Persons 2 and 3.

     (c)  Since February 18, 1997, the Persons filing this 
     Schedule 13D, as amended, have acquired the following shares 
     of Common Stock:



CUSIP No. 515707107
Page 6 of 7 Pages	


                     Amount of Securities
          Date of        Acquired         Price per           
Person  Transaction     (Disposed)        Share      Transaction

1         4/18/97         24,000           1.66       Open Market Purchase
1         4/30/97          3,300           1.77       Open Market Purchase
1         4/30/97          2,000           1.71       Open Market Purchase

Note 1:  Person 2 was granted options to purchase 40,000 shares of 
Common Stock under Issuer's Plan on September 13, 1995.  Options 
to purchase 35,000 shares of Common Stock are currently exercisable 
or will be exercisable within the next sixty days.



********************

CUSIP No. 515707107
Page 7 of 7 Pages

          After reasonable inquiry and to the best of the 
undersigned's knowledge, the undersigned certify that the 
information set forth in this statement is true, complete,
and correct. 

Dated:                   May 2, 1997

TRIGRAN INVESTMENTS, L.P., an Illinois limited partnership

By:  Trigran Investments, Inc., general partner

       By:  /s/ Douglas Granat, President

/s/ Kenneth Granat

THE GRANAT FAMILY LIMITED PARTNERSHIP, an Illinois
   limited partnership

       By:  /s/ Kenneth Granat, General Partner



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission